Regulus Therapeutics
RGLS
#8816
Rank
A$0.14 B
Marketcap
$2.25
Share price
5.00%
Change (1 day)
10.72%
Change (1 year)

Regulus Therapeutics (RGLS) - Total assets

Total assets on the balance sheet as of June 2024 : A$0.15 Billion

According to Regulus Therapeutics's latest financial reports the company's total assets are A$0.15 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2022-12-31A$68.64 M-27.3%
2021-12-31A$94.42 M93.07%
2020-12-31A$48.9 M-18.63%
2019-12-31A$60.1 M51.61%
2018-12-31A$39.64 M-60.22%
2017-12-31A$99.66 M-28.63%
2016-12-31A$0.13 B-27.89%
2015-12-31A$0.19 B-7.57%
2014-12-31A$0.20 B51.87%
2013-12-31A$0.13 B38.5%
2012-12-31A$99.61 M138.19%
2011-12-31A$41.82 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$119.14 B 74,515.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$213.32 B 133,492.33%๐Ÿ‡ซ๐Ÿ‡ท France
A$43.42 B 27,093.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$160.02 B 100,112.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$6.44 B 3,938.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-10.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$143.65 B 89,864.37%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA